Inflation Reduction Act Impact on Clinical Tria...

By João L. Carapinha

March 26, 2026

The Inflation Reduction Act Impact is becoming evident in early data on industry-sponsored clinical trials. A recently published JME article examines how the Drug Price Negotiation Program (DPNP) introduced by the IRA may be altering investment in...
EU Alzheimer Approval Challenges: Anavex Withdraws Blarcamesine Application A...
South Africa Health Reform: Revitalizing the Crisis-Stricken Sector
NICE Pembrolizumab Recommendation for Locally Advanced Head and Neck Cancer T...
PEPFAR TB Impact: Averting Millions of Cases and Deaths Among HIV Patients
Vitamin B6 Depletion Risk in Carbidopa/Levodopa Therapy and Seizure Implications
Advancing Collaborative TB Innovation to Tackle Drug Resistance
Citation Analysis of Real-World Evidence in Medicare Drug Price Negotiations
Serplulimab Lung Cancer Treatment: Evaluation of Clinical and Economic Impact...
Cost-Effectiveness of T1D Screening Effectiveness in Canadian Children
Novartis Acquires Mutant-Selective PI3Kα Inhibitor to Enhance Breast Cancer T...
Semaglutide India Partnership: Enhancing Access to Diabetes Treatment
Wegovy HD Approval: A Game Changer in Obesity Treatment and Weight Loss Efficacy